Fairvalue-Calculator Fairvalue-Calculator
EN DE

Fluicell AB (FLUI) Fair Value & Analysis

Healthcare · SE · Market cap 64.0M SEK

Pricekr 32.30
Fair Valuekr 35.71
Upside+10.6%
Quality95/100
Evidence: Low Range kr 26.78 – kr 44.64

Fair value as of: Jun 24, 2026

Analysis

Fluicell AB (FLUI) currently trades at kr 32.30, while our model-based Fair Value estimate is kr 35.71 — implying the stock looks roughly 10.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that produces single cell arrays to organoids and complex tissues; Nexocyte, a platform for universal tissue production; and Biopixlar AER, a single-cell bioprinting platform that fits into a biosafety cabinet. Fluicell AB (publ) was incorporated in 2012 and is based in Mölndal, Sweden.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Fluicell AB (FLUI) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 35.71 versus a price of kr 32.30 — about +11% (undervalued). Model-based estimate, not financial advice.
What is the fair value of FLUI?
Our 21-model fair value for Fluicell AB is kr 35.71 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 32.30.
What is the quality score of FLUI?
Fluicell AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.